
Information
Rate, thrombus risk and personalized monitoring.
No.
The need for anticoagulation is determined by the risk of a thromboembolic event and not simply by the fact that atrial fibrillation is present.
The decision is individualized based on age, history and co-morbidities.
It is a clinical tool used to assess the risk of stroke in patients with atrial fibrillation.
It is not a therapeutic decision in itself and is interpreted in the context of the overall clinical picture.
Yes.
Paroxysmal atrial fibrillation can start and stop spontaneously. It may therefore not appear on a standard ECG if an episode is not happening at that moment.
Depending on how often episodes occur, Holter monitoring or a longer period of heart rhythm recording may be needed.
Rate control mainly aims to keep the heart rate at appropriate levels.
Rhythm control aims to restore and maintain sinus rhythm.
The best strategy is not the same for everyone.
Ablation may be a treatment option in selected patients, depending on symptoms, type of atrial fibrillation, response to prior therapy, and overall cardiac profile.
In many patients yes, but the appropriate intensity depends on arrhythmia control, symptoms, and the presence of other heart disease.
Yes.
Obesity, increased alcohol consumption, hypertension and sleep apnea can affect the onset and recurrence of atrial fibrillation.
Addressing these factors is part of overall treatment.
Every person has a different history. The right answer starts with personal assessment.